LaserAway's 20-Year Triumph: A New Blueprint for Scaling Healthcare

LOS ANGELES, CA – August 28, 2026 – As LaserAway cuts the ribbon on its 229th clinic today in University Park, Florida, it marks more than just another dot on a rapidly expanding map. The milestone coincides with the company’s 20th anniversary and illuminates a remarkable statistic that stands in stark defiance of retail and healthcare industry norms: two decades of uninterrupted growth without a single clinic closure. In a landscape littered with franchising failures and volatile market shifts, LaserAway's journey from a single West Hollywood location to the nation's most prominent aesthetic dermatology brand offers a compelling case study in strategy, discipline, and market disruption.

Founded in 2006 by Dr. Roy Winston and the brothers Scott, Brock, and Todd Heckmann, the company was built on a simple yet transformative premise: to make medically supervised, effective aesthetic treatments accessible to everyone. This mission has propelled the firm’s expansion across 36 states, creating a formidable presence in the booming U.S. aesthetic services market, which swelled to over $22 billion in 2026. But the secret to its resilience isn't just its mission; it's the meticulously crafted operational engine running under the hood.

A Disciplined Ascent: The No-Franchise Growth Engine

At the core of LaserAway’s success is a strategic decision to reject the franchise model, a path commonly taken by service-based chains to achieve rapid, low-capital expansion. Instead, every one of its 229 locations is privately owned and operated. This corporate-owned structure, while significantly more capital-intensive, provides the company with an unparalleled level of control over quality, brand messaging, and patient experience.

"When we opened our first clinic on Sunset Boulevard, we knew there was a massive opportunity to make these treatments accessible to everyone—not just a privileged few," said Scott Heckmann, co-founder and CEO of LaserAway, in a statement. This vision required a foundation of trust and consistency that franchising can often dilute. By maintaining full ownership, the company ensures that from Miami to Los Angeles, every clinic adheres to the same rigorous medical protocols and service standards.

This disciplined approach stands in contrast to competitors in the broader wellness space who have used franchising to achieve larger storefront counts. However, industry analysis suggests that within the specialized and lucrative segment of injectable and laser-led medical aesthetics, LaserAway’s model has allowed it to become a revenue powerhouse. While a competitor like Milan Laser Hair Removal also utilizes a corporate-run model and boasts a higher clinic count, LaserAway's comprehensive service menu—from Botox to body contouring—positions it uniquely. This strategy of deep, controlled growth has been fueled by a market ripe for investment, with private equity firms increasingly drawn to the recurring revenue and high growth potential of the aesthetics sector.

The Clinical Blueprint: Marrying Medical Rigor with Retail Access

LaserAway’s second strategic pillar is its fusion of medical professionalism with consumer-friendly accessibility. The company has effectively democratized procedures once confined to sterile dermatology offices, repackaging them in an environment that feels, as Heckmann puts it, "approachable and empowering." This is not a spa staffed by aestheticians; it's a clinical operation. The company is explicit that all treatments are performed by licensed medical professionals, including Nurse Practitioners (NPs), Physician Assistants (PAs), and Registered Nurses (RNs).

Overseeing this network is a robust medical governance structure, led by Chief Medical Officer Dr. Will Kirby and a medical board of over 25 board-certified dermatologists. This centralized oversight is critical in an industry where state-level regulations on the scope of practice for non-physician providers can vary widely. By establishing a high, uniform standard of care and providing extensive training, the firm mitigates risk and builds significant consumer confidence. This clinical integrity is a key differentiator in a crowded field where 81% of aesthetic clinics are single-location practices, often without the resources for such a comprehensive oversight framework.

The company’s definition of “accessible” also extends to pricing. Through aggressive promotions, bundled packages, and readily available financing options, LaserAway has lowered the barrier to entry for a broader demographic. This strategy taps directly into a powerful market trend: the growing demand for non-invasive and minimally-invasive procedures, which are projected to drive the U.S. aesthetic medicine market to $32 billion by 2033. By making treatments more affordable, the company has successfully expanded its customer base beyond the traditionally affluent to include younger consumers focused on “preventative” aesthetics and a wider middle-class clientele.

Florida's Aesthetic Boom: A Microcosm of a National Trend

The opening in University Park is not a random pin on the map. It represents a strategic push into one of the nation’s hottest markets for beauty and wellness. Florida’s demographics, coupled with a lifestyle that prioritizes appearance, make it a crucial battleground for aesthetic service providers. LaserAway’s entry into the Sarasota-adjacent community introduces a major national player into a market predominantly served by smaller, independent medspas.

This expansion will undoubtedly intensify local competition, forcing smaller businesses to differentiate on service, specialize in niche treatments, or compete on price. For consumers, the arrival of a recognized brand like LaserAway brings more choice, the assurance of a standardized experience, and the weight of a national reputation. It’s a classic example of how scaled businesses can reshape local economies and consumer behavior.

As LaserAway celebrates twenty years of flawless execution, its story offers a powerful lesson at the intersection of healthcare and business. The company has proven that it is possible to scale a medically-sensitive service nationwide without sacrificing quality control. Its dual focus on clinical rigor and consumer accessibility has not only fueled two decades of growth but has fundamentally altered the public’s relationship with aesthetic dermatology. As the company opens its 229th set of doors in Florida, it’s not just celebrating an anniversary; it’s cementing a business model that could very well become the standard for consumer-facing healthcare in the decade to come.